Clinical Utility of Residual Hearing in the Cochlear Implant Ear

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 10, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Hearing Loss, SensorineuralHearing LossHearing Loss, Bilateral
Interventions
DEVICE

Electrocochleography

"The use of ECochG monitoring will be employed. This will be conducted intraoperatively during the entire portion of the CI electrode insertion component.~For the purposes of this clinical trial, the stimulus will consist of a 500 Hz tone burst presented at \~105-110 dB SPL. This was chosen due to the time and resource limitations in the operating room. Hence, the surgical team can only utilize a very limited dataset for intraoperative decision making and previous studies have demonstrated that 500 Hz stimulation offers the most robust, reliable, and useful ECochG signal during electrode insertions."

Trial Locations (5)

27599

RECRUITING

University of North Carolina, Chapel Hill, Chapel Hill

43210

RECRUITING

Ohio State University Eye and Ear Institute, Columbus

53226

RECRUITING

Medical College of Wisconsin, Milwaukee

55905

RECRUITING

Mayo Clinic, Rochester

63110

RECRUITING

Washington University in St. Louis, St Louis

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

Ohio State University

OTHER